ABVC BioPharma, Inc. (ABVC) vs Aytu BioPharma, Inc. (AYTU)

A side-by-side comparison of ABVC BioPharma, Inc. and Aytu BioPharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ABVC vs AYTU

growth of $100 · dividends reinvested · last 10y
ABVC -99.7% (-44.6%/yr)AYTU -100.0% (-68.5%/yr)ABVC compounded faster over this window
Log scale — wide-divergence pair
0000110100Start $10020182020202220242026$0$0
ABVC AYTU

ABVC vs AYTU: by the numbers

  • •ABVC is the larger company ($25M vs $22M market cap).
  • •Both run net losses; ABVC's is the smaller (0.00% vs -24.76% net margin).

Metrics side by side

Valuation

MetricABVCAYTU
P/S ratioN/A0.38
P/B ratio2.450.62
FCF yieldN/A14.78%

Profitability

MetricABVCAYTU
Gross margin0.00%63.95%
Operating margin0.00%-14.44%
Net margin0.00%-24.76%
ROE-76.82%-40.40%
ROIC-53.34%-14.21%

Growth (annualized)

MetricABVCAYTU
Revenue CAGR (5Y)N/A-2.59%
Total return CAGR (5Y)-46.33%-48.14%

Frequently asked

How have ABVC and AYTU total returns compared?
Over the past 10 years, ABVC delivered -44.60% and AYTU delivered -68.87% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.